Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus
- PMID: 14556979
- PMCID: PMC7119665
- DOI: 10.1016/s0165-2478(03)00138-x
Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus
Abstract
Toll-like receptors (TLR) induce innate immune responses upon stimulation by a wide variety of pathogens. TLR4 has been implicated in innate immunity against respiratory syncytial virus (RSV) by an interaction with the viral envelope fusion (F) protein. Sendai virus (mouse parainfluenza type 1) shares many features with RSV, including a structurally and functionally similar F protein. To determine the role of TLR4 in host defense against Sendai virus respiratory tract infection, TLR4 mutant and wildtype mice were intranasally infected with Sendai virus. Sendai infection resulted in an increase in viral RNA copies in lung homogenates peaking on day 4. Pulmonary viral loads, histopathology, cytokine levels and leukocyte influx were similar in TLR4 mutant and wildtype mice. In spite of the structural similarities shared by the F proteins of Sendai virus and RSV, TLR4 is not involved in host defense against respiratory tract infection with Sendai virus.
Figures
Similar articles
-
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis.Microb Pathog. 2004 Oct;37(4):185-91. doi: 10.1016/j.micpath.2004.06.010. Microb Pathog. 2004. PMID: 15458779
-
Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.J Virol. 2015 Apr;89(7):3568-83. doi: 10.1128/JVI.03581-14. Epub 2015 Jan 14. J Virol. 2015. PMID: 25589649 Free PMC article.
-
Dual role of NOX2 in respiratory syncytial virus- and sendai virus-induced activation of NF-kappaB in airway epithelial cells.J Immunol. 2008 May 15;180(10):6911-22. doi: 10.4049/jimmunol.180.10.6911. J Immunol. 2008. PMID: 18453612
-
Can MMTV exploit TLR4?Trends Microbiol. 2002 Jul;10(7):303-5; discussion 305-6. doi: 10.1016/s0966-842x(02)02385-5. Trends Microbiol. 2002. PMID: 12110201 Review.
-
Innate immunity and toll-like receptors: clinical implications of basic science research.J Pediatr. 2004 Apr;144(4):421-9. doi: 10.1016/j.jpeds.2004.01.057. J Pediatr. 2004. PMID: 15069387 Review.
Cited by
-
Pneumonia virus of mice: severe respiratory infection in a natural host.Immunol Lett. 2008 Jun 15;118(1):6-12. doi: 10.1016/j.imlet.2008.03.013. Epub 2008 Apr 22. Immunol Lett. 2008. PMID: 18471897 Free PMC article. Review.
-
Innate immunity to influenza virus: implications for future therapy.Expert Rev Clin Immunol. 2008 Jul 1;4(4):497-514. doi: 10.1586/1744666X.4.4.497. Expert Rev Clin Immunol. 2008. PMID: 19756245 Free PMC article.
-
Host responses from innate to adaptive immunity after vaccination: molecular and cellular events.Mol Cells. 2009 Jan 31;27(1):5-14. doi: 10.1007/s10059-009-0015-1. Epub 2009 Feb 5. Mol Cells. 2009. PMID: 19214429 Free PMC article. Review.
-
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses.Immunity. 2005 Nov;23(5):465-78. doi: 10.1016/j.immuni.2005.09.016. Immunity. 2005. PMID: 16286015 Free PMC article.
-
Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.J Immunol. 2011 Jan 15;186(2):1151-61. doi: 10.4049/jimmunol.1001751. Epub 2010 Dec 17. J Immunol. 2011. PMID: 21169550 Free PMC article.
References
-
- Aderem A., Ulevitch R.J. Nature. 2000;406:782–787. - PubMed
-
- Kaisho T., Akira S. Biochim. Biophys. Acta. 2002;1589:1–13. - PubMed
-
- Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. J. Biol. Chem. 1999;274:17406–17409. - PubMed
-
- Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., Aderem A. Nature. 2001;410:1099–1103. - PubMed
-
- Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. Nature. 2000;408:740–745. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources